source
- UCB shares dip as investors worry forecast may be too optimistic despite Bimzelx sales beatUCB reported that sales of its lead drug Bimzelx exceeded analysts' expectations for the quarter. However, the company also gave a full-year revenue outlook that some investors view as overly opti…
- Sanofi CEO Garijo outlines R&D overhaul, M&A push and China focus to counter patent cliffGarijo, three months into her tenure as Sanofi chief executive, shared her strategy for the company’s next phase of growth. She said the firm will conduct a thorough cleanup of its research and de…